{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:32:32Z","timestamp":1790627552695,"version":"4.1.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Wiskott-Aldrich syndrome protein (WASp) is mutated in the severe immunodeficiency disease Wiskott-Aldrich syndrome (WAS). The function of B cells and the physiologic alterations in WAS remain unclear. We show that B cells from WAS patients exhibited decreased motility and had reduced capacity to migrate, adhere homotypically, and form long protrusions after in vitro culture. WASp-deficient murine B cells also migrated less well to chemokines. Upon antigen challenge, WASp-deficient mice mounted a reduced and delayed humoral immune response to both T-cell\u2013dependent and \u2013independent antigens. This was at least in part due to deficient migration and homing of B cells. In addition, the germinal center reaction was reduced in WASp-deficient mice. Thus, WASp is crucial for optimal B-cell responses and plays a pivotal role in the primary humoral immune response.<\/jats:p>","DOI":"10.1182\/blood-2004-03-1003","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T21:16:43Z","timestamp":1095801403000},"page":"1144-1152","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":129,"title":["Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response"],"prefix":"10.1182","volume":"105","author":[{"given":"Lisa","family":"Westerberg","sequence":"first","affiliation":[{"name":"From the Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm, Sweden; the Institute of Child Health, University College London, London, United Kingdom; and the Department of Immunology, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Larsson","sequence":"additional","affiliation":[{"name":"From the Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm, Sweden; the Institute of Child Health, University College London, London, United Kingdom; and the Department of Immunology, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Hardy","sequence":"additional","affiliation":[{"name":"From the Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm, Sweden; the Institute of Child Health, University College London, London, United Kingdom; and the Department of Immunology, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ferna\u0301ndez","sequence":"additional","affiliation":[{"name":"From the Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm, Sweden; the Institute of Child Health, University College London, London, United Kingdom; and the Department of Immunology, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[{"name":"From the Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm, Sweden; the Institute of Child Health, University College London, London, United Kingdom; and the Department of Immunology, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Severinson","sequence":"additional","affiliation":[{"name":"From the Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm, Sweden; the Institute of Child Health, University College London, London, United Kingdom; and the Department of Immunology, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219131939500_REF1","doi-asserted-by":"crossref","unstructured":"Cyster JG. Lymphoid organ development and cell migration. Immunol Rev.2003;195: 5-14.","DOI":"10.1034\/j.1600-065X.2003.00075.x"},{"key":"2020021219131939500_REF2","doi-asserted-by":"crossref","unstructured":"Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell.1994;78: 635-644.","DOI":"10.1016\/0092-8674(94)90528-2"},{"key":"2020021219131939500_REF3","doi-asserted-by":"crossref","unstructured":"Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr.1994;125: 876-885.","DOI":"10.1016\/S0022-3476(05)82002-5"},{"key":"2020021219131939500_REF4","doi-asserted-by":"crossref","unstructured":"Thrasher AJ. WASp in immune-system organization and function. Nat Rev Immunol.2002;2: 635-646.","DOI":"10.1038\/nri884"},{"key":"2020021219131939500_REF5","doi-asserted-by":"crossref","unstructured":"Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature.2000;404: 151-158.","DOI":"10.1038\/35004513"},{"key":"2020021219131939500_REF6","doi-asserted-by":"crossref","unstructured":"Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet.2001;17: 313-317.","DOI":"10.1038\/85886"},{"key":"2020021219131939500_REF7","doi-asserted-by":"crossref","unstructured":"Kenney D, Cairns L, Remold-O'Donnell E, Peterson J, Rosen FS, Parkman R. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndome. Blood.1986;68: 1329-1332.","DOI":"10.1182\/blood.V68.6.1329.1329"},{"key":"2020021219131939500_REF8","doi-asserted-by":"crossref","unstructured":"Molina IJ, Kenney DM, Rosen FS, Remold-O'Donnel E. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med.1992;176: 867-874.","DOI":"10.1084\/jem.176.3.867"},{"key":"2020021219131939500_REF9","doi-asserted-by":"crossref","unstructured":"Gallego MD, Santamaria M, Pen\u0303a J, Molina IJ. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood.1997;90: 3089-3097.","DOI":"10.1182\/blood.V90.8.3089"},{"key":"2020021219131939500_REF10","doi-asserted-by":"crossref","unstructured":"Majstoravich S, Zhang J, Nicholson-Dykstra S, et al. Lymphocyte microvilli are dynamic, actin-dependent structures that do not require Wiskott-Aldrich syndrome protein (WASp) for their morphology. Blood.2004;104: 1396-1403.","DOI":"10.1182\/blood-2004-02-0437"},{"key":"2020021219131939500_REF11","doi-asserted-by":"crossref","unstructured":"Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity.1998;9: 81-91.","DOI":"10.1016\/S1074-7613(00)80590-7"},{"key":"2020021219131939500_REF12","doi-asserted-by":"crossref","unstructured":"Zhang J, Shehabeldin A, da Cruz LA, et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med.1999;190: 1329-1342.","DOI":"10.1084\/jem.190.9.1329"},{"key":"2020021219131939500_REF13","doi-asserted-by":"crossref","unstructured":"Cannon JL, Labno CM, Bosco G, et al. WASP recruitment to the T cell:APC contact site occurs independently of Cdc42 activation. Immunity.2001;15: 249-259.","DOI":"10.1016\/S1074-7613(01)00178-9"},{"key":"2020021219131939500_REF14","doi-asserted-by":"crossref","unstructured":"Dupre\u0301 L, Aiuti A, Trifari S, et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity.2002;17: 157-166.","DOI":"10.1016\/S1074-7613(02)00360-6"},{"key":"2020021219131939500_REF15","doi-asserted-by":"crossref","unstructured":"Orange JS, Ramesh N, Remold-O'Donnell E, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A.2002;99: 11351-11356.","DOI":"10.1073\/pnas.162376099"},{"key":"2020021219131939500_REF16","doi-asserted-by":"crossref","unstructured":"Badolato R, Sozzani S, Malacarne F, et al. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol.1998;161: 1026-1033.","DOI":"10.4049\/jimmunol.161.2.1026"},{"key":"2020021219131939500_REF17","doi-asserted-by":"crossref","unstructured":"Zicha D, Allen WE, Brickell PM, et al. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol.1998;101: 659-665.","DOI":"10.1046\/j.1365-2141.1998.00767.x"},{"key":"2020021219131939500_REF18","doi-asserted-by":"crossref","unstructured":"Binks M, Jones GE, Brickell PM, Kinnon C, Katz DR, Thrasher AJ. Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur J Immunol.1998;28: 3259-3267.","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3259::AID-IMMU3259>3.0.CO;2-B"},{"key":"2020021219131939500_REF19","doi-asserted-by":"crossref","unstructured":"Linder S, Nelson D, Weiss M, Aepfelbacher M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A.1999;96: 9648-9653.","DOI":"10.1073\/pnas.96.17.9648"},{"key":"2020021219131939500_REF20","doi-asserted-by":"crossref","unstructured":"Burns S, Thrasher AJ, Blundell MP, Machesky L, Jones GE. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood.2001;98: 1142-1149.","DOI":"10.1182\/blood.V98.4.1142"},{"key":"2020021219131939500_REF21","doi-asserted-by":"crossref","unstructured":"Leverrier Y, Lorenzi R, Blundell MP, et al. Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J Immunol.2001;166: 4831-4834.","DOI":"10.4049\/jimmunol.166.8.4831"},{"key":"2020021219131939500_REF22","doi-asserted-by":"crossref","unstructured":"Lacout C, Haddad E, Sabri S, et al. A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome. Blood.2003; 102: 1282-1289.","DOI":"10.1182\/blood-2002-07-2099"},{"key":"2020021219131939500_REF23","doi-asserted-by":"crossref","unstructured":"Simon HU, Mills GB, Hashimoto S, Siminovitch KA. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J Clin Invest.1992;90: 1396-1405.","DOI":"10.1172\/JCI116006"},{"key":"2020021219131939500_REF24","doi-asserted-by":"crossref","unstructured":"Henriquez NV, Rijkers GT, Zegers BJ. Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome. J Immunol.1994;153: 395-399.","DOI":"10.4049\/jimmunol.153.1.395"},{"key":"2020021219131939500_REF25","doi-asserted-by":"crossref","unstructured":"Facchetti F, Blanzuoli L, Vermi W, et al. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome. J Pathol.1998;185: 99-107.","DOI":"10.1002\/(SICI)1096-9896(199805)185:1<99::AID-PATH48>3.0.CO;2-L"},{"key":"2020021219131939500_REF26","doi-asserted-by":"crossref","unstructured":"Westerberg L, Greicius G, Snapper SB, Aspenstro\u0308m P, Severinson E. Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes. Blood.2001;98: 1086-1094.","DOI":"10.1182\/blood.V98.4.1086"},{"key":"2020021219131939500_REF27","doi-asserted-by":"crossref","unstructured":"Davey EJ, Thyberg J, Conrad DH, Severinson E. Regulation of cell morphology in B lymphocytes by IL-4: evidence for induced cytoskeletal changes. J Immunol.1998;160: 5366-5373.","DOI":"10.4049\/jimmunol.160.11.5366"},{"key":"2020021219131939500_REF28","doi-asserted-by":"crossref","unstructured":"Greicius G, Tamosiunas V, Severinson E. Assessment of the role of leucocyte function-associated antigen-1 in homotypic adhesion of activated B lymphocytes. Scand J Immunol.1998;48: 642-650.","DOI":"10.1046\/j.1365-3083.1998.00442.x"},{"key":"2020021219131939500_REF29","doi-asserted-by":"crossref","unstructured":"Jerne NK, Nordin AA. Plaque formation in agar by single antibody-producing cells. Science.1963; 140: 405.","DOI":"10.1126\/science.140.3565.405"},{"key":"2020021219131939500_REF30","doi-asserted-by":"crossref","unstructured":"Fernandez C, Mo\u0308ller G. Serum antibody and cellular immune response in mice to dextran B512. Cell Immunol.1990;131: 41-51.","DOI":"10.1016\/0008-8749(90)90233-H"},{"key":"2020021219131939500_REF31","doi-asserted-by":"crossref","unstructured":"Klein C, Nguyen D, Liu CH, et al. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood.2003;101: 2159-2166.","DOI":"10.1182\/blood-2002-05-1423"},{"key":"2020021219131939500_REF32","doi-asserted-by":"crossref","unstructured":"Haddad E, Zugaza JL, Louache F, et al. The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood.2001;97: 33-38.","DOI":"10.1182\/blood.V97.1.33"},{"key":"2020021219131939500_REF33","doi-asserted-by":"crossref","unstructured":"Snover DC, Frizzera G, Spector BD, Perry GS III, Kersey JH. Wiskott-Aldrich syndrome: histopathologic findings in the lymph nodes and spleens of 15 patients. Hum Pathol.1981;12: 821-831.","DOI":"10.1016\/S0046-8177(81)80085-8"},{"key":"2020021219131939500_REF34","doi-asserted-by":"crossref","unstructured":"Vermi W, Blanzuoli L, Kraus MD, et al. The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the disease. Am J Surg Pathol.1999;23: 182-191.","DOI":"10.1097\/00000478-199902000-00007"},{"key":"2020021219131939500_REF35","doi-asserted-by":"crossref","unstructured":"Oliver AM, Martin F, Kearney JF. IgMhigh CD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol.1999;162: 7198-7207.","DOI":"10.4049\/jimmunol.162.12.7198"},{"key":"2020021219131939500_REF36","doi-asserted-by":"crossref","unstructured":"Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol.2002;2: 323-335.","DOI":"10.1038\/nri799"},{"key":"2020021219131939500_REF37","doi-asserted-by":"crossref","unstructured":"Xu J, Foy TM, Laman JD, et al. Mice deficient for the CD40 ligand. Immunity.1994;1: 423-431.","DOI":"10.1016\/1074-7613(94)90073-6"},{"key":"2020021219131939500_REF38","doi-asserted-by":"crossref","unstructured":"Katada Y, Tanaka T, Ochi H, et al. B cell-B cell interaction through intercellular adhesion molecule-1 and lymphocyte functional antigen-1 regulates immunoglobulin E synthesis by B cells stimulated with interleukin-4 and anti-CD40 antibody. Eur J Immunol.1996;26: 192-200.","DOI":"10.1002\/eji.1830260130"},{"key":"2020021219131939500_REF39","doi-asserted-by":"crossref","unstructured":"Lindhout E, Koopman G, Pals ST, de Groot C. Triple check for antigen specificity of B cells during germinal centre reactions. Immunol Today.1997;18: 573-577.","DOI":"10.1016\/S0167-5699(97)01160-2"},{"key":"2020021219131939500_REF40","doi-asserted-by":"crossref","unstructured":"Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O'Donnell E. Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol.2004;136: 104-110.","DOI":"10.1111\/j.1365-2249.2004.02409.x"},{"key":"2020021219131939500_REF41","doi-asserted-by":"crossref","unstructured":"Guinamard R, Okigaki M, Schlessinger J, Ravetch JV. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol.2000;1: 31-36.","DOI":"10.1038\/76882"},{"key":"2020021219131939500_REF42","doi-asserted-by":"crossref","unstructured":"Fukui Y, Hashimoto O, Sanui T, et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature.2001; 412: 826-831.","DOI":"10.1038\/35090591"},{"key":"2020021219131939500_REF43","doi-asserted-by":"crossref","unstructured":"Girkontaite I, Missy K, Sakk V, et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol.2001;2: 855-862.","DOI":"10.1038\/ni0901-855"},{"key":"2020021219131939500_REF44","doi-asserted-by":"crossref","unstructured":"Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science2002;297: 409-412.","DOI":"10.1126\/science.1071632"},{"key":"2020021219131939500_REF45","doi-asserted-by":"crossref","unstructured":"Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science.1998;281: 96-99.","DOI":"10.1126\/science.281.5373.96"},{"key":"2020021219131939500_REF46","doi-asserted-by":"crossref","unstructured":"Reif K, Ekland EH, Ohl L, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature.2002; 416: 94-99.","DOI":"10.1038\/416094a"},{"key":"2020021219131939500_REF47","doi-asserted-by":"crossref","unstructured":"Westerberg L, Wallin RP, Greicius G, Ljunggren HG, Severinson E. Efficient antigen presentation of soluble, but not particulate, antigen in the absence of Wiskott-Aldrich syndrome protein. Immunology.2003;109: 384-391.","DOI":"10.1046\/j.1365-2567.2003.01668.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/3\/1144\/1705616\/zh800305001144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/3\/1144\/1705616\/zh800305001144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T06:23:55Z","timestamp":1682749435000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/3\/1144\/19612\/WiskottAldrich-syndrome-protein-deficiency-leads"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-03-1003","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,1]]}}}